557 related articles for article (PubMed ID: 8523347)
1. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
2. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.
Espinoza LR; Jara LJ; Silveira LH; Martínez-Osuna P; Zwolinska JB; Kneer C; Aguilar JL
Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088
[TBL] [Abstract][Full Text] [Related]
3. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
5. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
6. Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes.
Duhaut P; Berruyer M; Pinede L; Demolombe-Rague S; Loire R; Seydoux D; Dechavanne M; Ninet J; Pasquier J
Arthritis Rheum; 1998 Apr; 41(4):701-9. PubMed ID: 9550480
[TBL] [Abstract][Full Text] [Related]
7. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes.
Duhaut P; Bosshard S; Calvet A; Pinede L; Demolombe-Rague S; Dumontet C; Loire R; Seydoux D; Ninet J; Pasquier J; Aymard M
J Rheumatol; 1999 Feb; 26(2):361-9. PubMed ID: 9972970
[TBL] [Abstract][Full Text] [Related]
8. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
[TBL] [Abstract][Full Text] [Related]
9. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
[TBL] [Abstract][Full Text] [Related]
10. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
[TBL] [Abstract][Full Text] [Related]
12. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.
Berthelot JM; Lamour A; Mottier D; Pennec YL; Dueymes M; Jouquan J; Le Goff P; Youinou P
Ann Med Interne (Paris); 1992; 143(7):429-32. PubMed ID: 1300861
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
Gonzalez-Gay MA; Garcia-Porrua C; Salvarani C; Olivieri I; Hunder GG
J Rheumatol; 2000 Sep; 27(9):2179-84. PubMed ID: 10990231
[TBL] [Abstract][Full Text] [Related]
14. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
Rovenský J; Tuchynová A; Poprac P; Blazíková S; Bosák V; Stvrtinová V
Vnitr Lek; 2006; 52(7-8):691-6. PubMed ID: 16967610
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
[TBL] [Abstract][Full Text] [Related]
16. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
Dababneh A; Gonzalez-Gay MA; Garcia-Porrua C; Hajeer A; Thomson W; Ollier W
J Rheumatol; 1998 Nov; 25(11):2140-5. PubMed ID: 9818656
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
Bahlas S; Ramos-Remus C; Davis P
J Rheumatol; 1998 Jan; 25(1):99-104. PubMed ID: 9458211
[TBL] [Abstract][Full Text] [Related]
18. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94.
Gran JT; Myklebust G
J Rheumatol; 1997 Sep; 24(9):1739-43. PubMed ID: 9292797
[TBL] [Abstract][Full Text] [Related]
19. Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases.
Manna R; Latteri M; Cristiano G; Todaro L; Scuderi F; Gasbarrini G
Br J Rheumatol; 1998 Feb; 37(2):208-10. PubMed ID: 9569078
[TBL] [Abstract][Full Text] [Related]
20. Giant cell arteritis without clinically evident vascular involvement in a defined population.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
Arthritis Rheum; 2004 Apr; 51(2):274-7. PubMed ID: 15077272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
